カテゴリ： 世界, 医療/バイオ, Market Monitor Global

冠動脈バイパス移植手術用パイプラインのグローバル市場展望 2023年-2029年：内胸動脈手術用パイプライン、橈骨動脈手術用パイプライン、右胃大網動脈手術用パイプライン

■ 英語タイトル：Coronary Artery Bypass Graft Surgery Pipeline Market, Global Outlook and Forecast 2023-2029

調査会社Market Monitor Global社が発行したリサーチレポート（データ管理コード：MMG23LY7492）■ 発行会社/調査会社：Market Monitor Global
■ 商品コード：MMG23LY7492
■ 発行日：2023年7月
■ 調査対象地域：グローバル、北米、アメリカ、ヨーロッパ、アジア、日本、中国、東南アジア、インド、南米、中東・アフリカなど
■ 産業分野：医療機器＆消耗品
■ ページ数：112
■ レポート言語：英語
■ レポート形式：PDF
■ 納品方式：Eメール（受注後2-3営業日）
■ 販売価格オプション（消費税別）
Single User（1名様閲覧用）USD3,250 ⇒換算￥494,000見積依頼/購入/質問フォーム
Multi User（20名様閲覧用）USD4,225 ⇒換算￥642,200見積依頼/購入/質問フォーム
Enterprise User（閲覧人数制限なし）USD4,875 ⇒換算￥741,000見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご購入に関する詳細案内はご利用ガイドでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いも可能）
※Market Monitor Global社の概要及び新刊レポートはこちらでご確認いただけます。
★グローバルリサーチ資料[冠動脈バイパス移植手術用パイプラインのグローバル市場展望 2023年-2029年：内胸動脈手術用パイプライン、橈骨動脈手術用パイプライン、右胃大網動脈手術用パイプライン]についてメールでお問い合わせはこちら
*** レポート概要（サマリー）***

当調査レポートは次の情報を含め、世界の冠動脈バイパス移植手術用パイプライン市場規模と予測を収録しています。・世界の冠動脈バイパス移植手術用パイプライン市場：売上、2018年-2023年、2024年-2029年
・世界の冠動脈バイパス移植手術用パイプライン市場：販売量、2018年-2023年、2024年-2029年
・世界のトップ5企業、2022年

世界の冠動脈バイパス移植手術用パイプライン市場は2022年に000Mドルと評価され、予測期間中に000％のCAGRで2029年までに000Mドルに達すると予測されています。米国市場は2022年に000Mドルと推定されており、中国は2029年までに000Mドルに達すると予測されています。「内胸動脈手術用パイプライン」セグメントは今後6年間、000%のCAGRで2029年までに000Mドルに成長すると予測されています。

冠動脈バイパス移植手術用パイプラインのグローバル主要企業は、PetVivo Holdings Inc、 Medical 21 Inc、 AdvanSource Biomaterials Corporation、 Axcelon Biopolymers Corp、 enVVeno Medical Corp、 Coromedic Ltd.、 iiTech BV、 Neograft Technologies Inc、 RegenMedTX LLC、 Elana bv、 Rox Medical Inc、 Synovis Micro Companies Alliance Inc、 Thoratec LLC、 SeamVad Ltd.、 Xeltis AGなどです。2022年にトップ5企業がグローバル売上シェアの約000%を占めています。

MARKET MONITOR GLOBAL（MMG）は、冠動脈バイパス移植手術用パイプラインのメーカー、サプライヤー、流通業者、および業界の専門家を調査しました。これには、販売量、売上、需要、価格変動、製品タイプ、最近の動向と計画、産業トレンド、成長要因、課題、阻害要因、潜在的なリスクなどが含まれます。

【セグメント別市場分析】

世界の冠動脈バイパス移植手術用パイプライン市場：タイプ別、2018年-2023年、2024年-2029年
世界の冠動脈バイパス移植手術用パイプライン市場：タイプ別市場シェア、2022年
・内胸動脈手術用パイプライン、橈骨動脈手術用パイプライン、右胃大網動脈手術用パイプライン

世界の冠動脈バイパス移植手術用パイプライン市場：用途別、2018年-2023年、2024年-2029年
世界の冠動脈バイパス移植手術用パイプライン市場：用途別市場シェア、2022年
・病院、診療所、その他

世界の冠動脈バイパス移植手術用パイプライン市場：地域・国別、2018年-2023年、2024年-2029年
世界の冠動脈バイパス移植手術用パイプライン市場：地域別市場シェア、2022年
・北米：アメリカ、カナダ、メキシコ
・ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア
・アジア：中国、日本、韓国、東南アジア、インド
・南米：ブラジル、アルゼンチン
・中東・アフリカ：トルコ、イスラエル、サウジアラビア、UAE

【競合分析】

また、当レポートは主要な市場参加者の分析を提供します。
・主要企業における冠動脈バイパス移植手術用パイプラインのグローバル売上、2018年-2023年
・主要企業における冠動脈バイパス移植手術用パイプラインのグローバル売上シェア、2022年
・主要企業における冠動脈バイパス移植手術用パイプラインのグローバル販売量、2018年-2023年
・主要企業における冠動脈バイパス移植手術用パイプラインのグローバル販売量シェア、2022年

さらに、当レポートは主要企業のプロファイルを提示します。
PetVivo Holdings Inc、 Medical 21 Inc、 AdvanSource Biomaterials Corporation、 Axcelon Biopolymers Corp、 enVVeno Medical Corp、 Coromedic Ltd.、 iiTech BV、 Neograft Technologies Inc、 RegenMedTX LLC、 Elana bv、 Rox Medical Inc、 Synovis Micro Companies Alliance Inc、 Thoratec LLC、 SeamVad Ltd.、 Xeltis AG

*************************************************************

・調査・分析レポートの概要
冠動脈バイパス移植手術用パイプライン市場の定義
市場セグメント
世界の冠動脈バイパス移植手術用パイプライン市場概要
当レポートの特徴・ベネフィット
調査手法と情報源

・世界の冠動脈バイパス移植手術用パイプライン市場規模
世界の冠動脈バイパス移植手術用パイプライン市場規模：2022年 VS 2029年
世界の冠動脈バイパス移植手術用パイプライン市場規模と予測 2018年-2029年

・競争状況
グローバルトップ企業
売上ベースでのグローバルトップ企業
企業別グローバルでの冠動脈バイパス移植手術用パイプラインの売上
グローバルトップ3およびトップ5企業、2022年売上ベース
グローバル企業の冠動脈バイパス移植手術用パイプライン製品タイプ
グローバルにおけるティア1、ティア2、ティア3企業

・タイプ別市場分析
タイプ区分：内胸動脈手術用パイプライン、橈骨動脈手術用パイプライン、右胃大網動脈手術用パイプライン
冠動脈バイパス移植手術用パイプラインのタイプ別グローバル売上・予測

・用途別市場分析
用途区分：病院、診療所、その他
冠動脈バイパス移植手術用パイプラインの用途別グローバル売上・予測

・地域別市場分析
地域別冠動脈バイパス移植手術用パイプライン市場規模 2022年と2029年
地域別冠動脈バイパス移植手術用パイプライン売上・予測
北米市場：アメリカ、カナダ、メキシコ
ヨーロッパ市場：ドイツ、フランス、イギリス、イタリア、ロシア
アジア市場：中国、日本、韓国、東南アジア、インド
南米市場：ブラジル、アルゼンチン
中東・アフリカ市場：トルコ、イスラエル、サウジアラビア、UAE

・主要企業のプロファイル（企業概要、事業概要、主要製品、売上、ニュースなど）
PetVivo Holdings Inc、 Medical 21 Inc、 AdvanSource Biomaterials Corporation、 Axcelon Biopolymers Corp、 enVVeno Medical Corp、 Coromedic Ltd.、 iiTech BV、 Neograft Technologies Inc、 RegenMedTX LLC、 Elana bv、 Rox Medical Inc、 Synovis Micro Companies Alliance Inc、 Thoratec LLC、 SeamVad Ltd.、 Xeltis AG
...

This report aims to provide a comprehensive presentation of the global market for Coronary Artery Bypass Graft Surgery Pipeline, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Coronary Artery Bypass Graft Surgery Pipeline. This report contains market size and forecasts of Coronary Artery Bypass Graft Surgery Pipeline in global, including the following market information:
Global Coronary Artery Bypass Graft Surgery Pipeline Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global Coronary Artery Bypass Graft Surgery Pipeline Market Sales, 2018-2023, 2024-2029, (K Units)
Global top five Coronary Artery Bypass Graft Surgery Pipeline companies in 2022 (%)
The global Coronary Artery Bypass Graft Surgery Pipeline market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is Forecast to Reach $ Million.
Internal Mammary Artery Surgery Pipeline Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Coronary Artery Bypass Graft Surgery Pipeline include PetVivo Holdings Inc, Medical 21 Inc, AdvanSource Biomaterials Corporation, Axcelon Biopolymers Corp, enVVeno Medical Corp, Coromedic Ltd., iiTech BV, Neograft Technologies Inc and RegenMedTX LLC, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Coronary Artery Bypass Graft Surgery Pipeline manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Coronary Artery Bypass Graft Surgery Pipeline Market, by Type, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Coronary Artery Bypass Graft Surgery Pipeline Market Segment Percentages, by Type, 2022 (%)
Internal Mammary Artery Surgery Pipeline
Radial Artery Surgery Pipeline
Right Gastroepiploic Artery Surgery Pipeline
Global Coronary Artery Bypass Graft Surgery Pipeline Market, by Application, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Coronary Artery Bypass Graft Surgery Pipeline Market Segment Percentages, by Application, 2022 (%)
Hospitals
Clinics
Others
Global Coronary Artery Bypass Graft Surgery Pipeline Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Coronary Artery Bypass Graft Surgery Pipeline Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Coronary Artery Bypass Graft Surgery Pipeline revenues in global market, 2018-2023 (Estimated), ($ millions)
Key companies Coronary Artery Bypass Graft Surgery Pipeline revenues share in global market, 2022 (%)
Key companies Coronary Artery Bypass Graft Surgery Pipeline sales in global market, 2018-2023 (Estimated), (K Units)
Key companies Coronary Artery Bypass Graft Surgery Pipeline sales share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
PetVivo Holdings Inc
Medical 21 Inc
AdvanSource Biomaterials Corporation
Axcelon Biopolymers Corp
enVVeno Medical Corp
Coromedic Ltd.
iiTech BV
Neograft Technologies Inc
RegenMedTX LLC
Elana bv
Rox Medical Inc
Synovis Micro Companies Alliance Inc
Thoratec LLC
SeamVad Ltd.
Xeltis AG
Outline of Major Chapters:
Chapter 1: Introduces the definition of Coronary Artery Bypass Graft Surgery Pipeline, market overview.
Chapter 2: Global Coronary Artery Bypass Graft Surgery Pipeline market size in revenue and volume.
Chapter 3: Detailed analysis of Coronary Artery Bypass Graft Surgery Pipeline manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Coronary Artery Bypass Graft Surgery Pipeline in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Coronary Artery Bypass Graft Surgery Pipeline capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.

*** レポート目次（コンテンツ）***

1 Introduction to Research & Analysis Reports
1.1 Coronary Artery Bypass Graft Surgery Pipeline Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Coronary Artery Bypass Graft Surgery Pipeline Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Coronary Artery Bypass Graft Surgery Pipeline Overall Market Size
2.1 Global Coronary Artery Bypass Graft Surgery Pipeline Market Size: 2022 VS 2029
2.2 Global Coronary Artery Bypass Graft Surgery Pipeline Revenue, Prospects & Forecasts: 2018-2029
2.3 Global Coronary Artery Bypass Graft Surgery Pipeline Sales: 2018-2029
3 Company Landscape
3.1 Top Coronary Artery Bypass Graft Surgery Pipeline Players in Global Market
3.2 Top Global Coronary Artery Bypass Graft Surgery Pipeline Companies Ranked by Revenue
3.3 Global Coronary Artery Bypass Graft Surgery Pipeline Revenue by Companies
3.4 Global Coronary Artery Bypass Graft Surgery Pipeline Sales by Companies
3.5 Global Coronary Artery Bypass Graft Surgery Pipeline Price by Manufacturer (2018-2023)
3.6 Top 3 and Top 5 Coronary Artery Bypass Graft Surgery Pipeline Companies in Global Market, by Revenue in 2022
3.7 Global Manufacturers Coronary Artery Bypass Graft Surgery Pipeline Product Type
3.8 Tier 1, Tier 2 and Tier 3 Coronary Artery Bypass Graft Surgery Pipeline Players in Global Market
3.8.1 List of Global Tier 1 Coronary Artery Bypass Graft Surgery Pipeline Companies
3.8.2 List of Global Tier 2 and Tier 3 Coronary Artery Bypass Graft Surgery Pipeline Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type – Global Coronary Artery Bypass Graft Surgery Pipeline Market Size Markets, 2022 & 2029
4.1.2 Internal Mammary Artery Surgery Pipeline
4.1.3 Radial Artery Surgery Pipeline
4.1.4 Right Gastroepiploic Artery Surgery Pipeline
4.2 By Type – Global Coronary Artery Bypass Graft Surgery Pipeline Revenue & Forecasts
4.2.1 By Type – Global Coronary Artery Bypass Graft Surgery Pipeline Revenue, 2018-2023
4.2.2 By Type – Global Coronary Artery Bypass Graft Surgery Pipeline Revenue, 2024-2029
4.2.3 By Type – Global Coronary Artery Bypass Graft Surgery Pipeline Revenue Market Share, 2018-2029
4.3 By Type – Global Coronary Artery Bypass Graft Surgery Pipeline Sales & Forecasts
4.3.1 By Type – Global Coronary Artery Bypass Graft Surgery Pipeline Sales, 2018-2023
4.3.2 By Type – Global Coronary Artery Bypass Graft Surgery Pipeline Sales, 2024-2029
4.3.3 By Type – Global Coronary Artery Bypass Graft Surgery Pipeline Sales Market Share, 2018-2029
4.4 By Type – Global Coronary Artery Bypass Graft Surgery Pipeline Price (Manufacturers Selling Prices), 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application – Global Coronary Artery Bypass Graft Surgery Pipeline Market Size, 2022 & 2029
5.1.2 Hospitals
5.1.3 Clinics
5.1.4 Others
5.2 By Application – Global Coronary Artery Bypass Graft Surgery Pipeline Revenue & Forecasts
5.2.1 By Application – Global Coronary Artery Bypass Graft Surgery Pipeline Revenue, 2018-2023
5.2.2 By Application – Global Coronary Artery Bypass Graft Surgery Pipeline Revenue, 2024-2029
5.2.3 By Application – Global Coronary Artery Bypass Graft Surgery Pipeline Revenue Market Share, 2018-2029
5.3 By Application – Global Coronary Artery Bypass Graft Surgery Pipeline Sales & Forecasts
5.3.1 By Application – Global Coronary Artery Bypass Graft Surgery Pipeline Sales, 2018-2023
5.3.2 By Application – Global Coronary Artery Bypass Graft Surgery Pipeline Sales, 2024-2029
5.3.3 By Application – Global Coronary Artery Bypass Graft Surgery Pipeline Sales Market Share, 2018-2029
5.4 By Application – Global Coronary Artery Bypass Graft Surgery Pipeline Price (Manufacturers Selling Prices), 2018-2029
6 Sights by Region
6.1 By Region – Global Coronary Artery Bypass Graft Surgery Pipeline Market Size, 2022 & 2029
6.2 By Region – Global Coronary Artery Bypass Graft Surgery Pipeline Revenue & Forecasts
6.2.1 By Region – Global Coronary Artery Bypass Graft Surgery Pipeline Revenue, 2018-2023
6.2.2 By Region – Global Coronary Artery Bypass Graft Surgery Pipeline Revenue, 2024-2029
6.2.3 By Region – Global Coronary Artery Bypass Graft Surgery Pipeline Revenue Market Share, 2018-2029
6.3 By Region – Global Coronary Artery Bypass Graft Surgery Pipeline Sales & Forecasts
6.3.1 By Region – Global Coronary Artery Bypass Graft Surgery Pipeline Sales, 2018-2023
6.3.2 By Region – Global Coronary Artery Bypass Graft Surgery Pipeline Sales, 2024-2029
6.3.3 By Region – Global Coronary Artery Bypass Graft Surgery Pipeline Sales Market Share, 2018-2029
6.4 North America
6.4.1 By Country – North America Coronary Artery Bypass Graft Surgery Pipeline Revenue, 2018-2029
6.4.2 By Country – North America Coronary Artery Bypass Graft Surgery Pipeline Sales, 2018-2029
6.4.3 US Coronary Artery Bypass Graft Surgery Pipeline Market Size, 2018-2029
6.4.4 Canada Coronary Artery Bypass Graft Surgery Pipeline Market Size, 2018-2029
6.4.5 Mexico Coronary Artery Bypass Graft Surgery Pipeline Market Size, 2018-2029
6.5 Europe
6.5.1 By Country – Europe Coronary Artery Bypass Graft Surgery Pipeline Revenue, 2018-2029
6.5.2 By Country – Europe Coronary Artery Bypass Graft Surgery Pipeline Sales, 2018-2029
6.5.3 Germany Coronary Artery Bypass Graft Surgery Pipeline Market Size, 2018-2029
6.5.4 France Coronary Artery Bypass Graft Surgery Pipeline Market Size, 2018-2029
6.5.5 U.K. Coronary Artery Bypass Graft Surgery Pipeline Market Size, 2018-2029
6.5.6 Italy Coronary Artery Bypass Graft Surgery Pipeline Market Size, 2018-2029
6.5.7 Russia Coronary Artery Bypass Graft Surgery Pipeline Market Size, 2018-2029
6.5.8 Nordic Countries Coronary Artery Bypass Graft Surgery Pipeline Market Size, 2018-2029
6.5.9 Benelux Coronary Artery Bypass Graft Surgery Pipeline Market Size, 2018-2029
6.6 Asia
6.6.1 By Region – Asia Coronary Artery Bypass Graft Surgery Pipeline Revenue, 2018-2029
6.6.2 By Region – Asia Coronary Artery Bypass Graft Surgery Pipeline Sales, 2018-2029
6.6.3 China Coronary Artery Bypass Graft Surgery Pipeline Market Size, 2018-2029
6.6.4 Japan Coronary Artery Bypass Graft Surgery Pipeline Market Size, 2018-2029
6.6.5 South Korea Coronary Artery Bypass Graft Surgery Pipeline Market Size, 2018-2029
6.6.6 Southeast Asia Coronary Artery Bypass Graft Surgery Pipeline Market Size, 2018-2029
6.6.7 India Coronary Artery Bypass Graft Surgery Pipeline Market Size, 2018-2029
6.7 South America
6.7.1 By Country – South America Coronary Artery Bypass Graft Surgery Pipeline Revenue, 2018-2029
6.7.2 By Country – South America Coronary Artery Bypass Graft Surgery Pipeline Sales, 2018-2029
6.7.3 Brazil Coronary Artery Bypass Graft Surgery Pipeline Market Size, 2018-2029
6.7.4 Argentina Coronary Artery Bypass Graft Surgery Pipeline Market Size, 2018-2029
6.8 Middle East & Africa
6.8.1 By Country – Middle East & Africa Coronary Artery Bypass Graft Surgery Pipeline Revenue, 2018-2029
6.8.2 By Country – Middle East & Africa Coronary Artery Bypass Graft Surgery Pipeline Sales, 2018-2029
6.8.3 Turkey Coronary Artery Bypass Graft Surgery Pipeline Market Size, 2018-2029
6.8.4 Israel Coronary Artery Bypass Graft Surgery Pipeline Market Size, 2018-2029
6.8.5 Saudi Arabia Coronary Artery Bypass Graft Surgery Pipeline Market Size, 2018-2029
6.8.6 UAE Coronary Artery Bypass Graft Surgery Pipeline Market Size, 2018-2029
7 Manufacturers & Brands Profiles
7.1 PetVivo Holdings Inc
7.1.1 PetVivo Holdings Inc Company Summary
7.1.2 PetVivo Holdings Inc Business Overview
7.1.3 PetVivo Holdings Inc Coronary Artery Bypass Graft Surgery Pipeline Major Product Offerings
7.1.4 PetVivo Holdings Inc Coronary Artery Bypass Graft Surgery Pipeline Sales and Revenue in Global (2018-2023)
7.1.5 PetVivo Holdings Inc Key News & Latest Developments
7.2 Medical 21 Inc
7.2.1 Medical 21 Inc Company Summary
7.2.2 Medical 21 Inc Business Overview
7.2.3 Medical 21 Inc Coronary Artery Bypass Graft Surgery Pipeline Major Product Offerings
7.2.4 Medical 21 Inc Coronary Artery Bypass Graft Surgery Pipeline Sales and Revenue in Global (2018-2023)
7.2.5 Medical 21 Inc Key News & Latest Developments
7.3 AdvanSource Biomaterials Corporation
7.3.1 AdvanSource Biomaterials Corporation Company Summary
7.3.2 AdvanSource Biomaterials Corporation Business Overview
7.3.3 AdvanSource Biomaterials Corporation Coronary Artery Bypass Graft Surgery Pipeline Major Product Offerings
7.3.4 AdvanSource Biomaterials Corporation Coronary Artery Bypass Graft Surgery Pipeline Sales and Revenue in Global (2018-2023)
7.3.5 AdvanSource Biomaterials Corporation Key News & Latest Developments
7.4 Axcelon Biopolymers Corp
7.4.1 Axcelon Biopolymers Corp Company Summary
7.4.2 Axcelon Biopolymers Corp Business Overview
7.4.3 Axcelon Biopolymers Corp Coronary Artery Bypass Graft Surgery Pipeline Major Product Offerings
7.4.4 Axcelon Biopolymers Corp Coronary Artery Bypass Graft Surgery Pipeline Sales and Revenue in Global (2018-2023)
7.4.5 Axcelon Biopolymers Corp Key News & Latest Developments
7.5 enVVeno Medical Corp
7.5.1 enVVeno Medical Corp Company Summary
7.5.2 enVVeno Medical Corp Business Overview
7.5.3 enVVeno Medical Corp Coronary Artery Bypass Graft Surgery Pipeline Major Product Offerings
7.5.4 enVVeno Medical Corp Coronary Artery Bypass Graft Surgery Pipeline Sales and Revenue in Global (2018-2023)
7.5.5 enVVeno Medical Corp Key News & Latest Developments
7.6 Coromedic Ltd.
7.6.1 Coromedic Ltd. Company Summary
7.6.2 Coromedic Ltd. Business Overview
7.6.3 Coromedic Ltd. Coronary Artery Bypass Graft Surgery Pipeline Major Product Offerings
7.6.4 Coromedic Ltd. Coronary Artery Bypass Graft Surgery Pipeline Sales and Revenue in Global (2018-2023)
7.6.5 Coromedic Ltd. Key News & Latest Developments
7.7 iiTech BV
7.7.1 iiTech BV Company Summary
7.7.2 iiTech BV Business Overview
7.7.3 iiTech BV Coronary Artery Bypass Graft Surgery Pipeline Major Product Offerings
7.7.4 iiTech BV Coronary Artery Bypass Graft Surgery Pipeline Sales and Revenue in Global (2018-2023)
7.7.5 iiTech BV Key News & Latest Developments
7.8 Neograft Technologies Inc
7.8.1 Neograft Technologies Inc Company Summary
7.8.2 Neograft Technologies Inc Business Overview
7.8.3 Neograft Technologies Inc Coronary Artery Bypass Graft Surgery Pipeline Major Product Offerings
7.8.4 Neograft Technologies Inc Coronary Artery Bypass Graft Surgery Pipeline Sales and Revenue in Global (2018-2023)
7.8.5 Neograft Technologies Inc Key News & Latest Developments
7.9 RegenMedTX LLC
7.9.1 RegenMedTX LLC Company Summary
7.9.2 RegenMedTX LLC Business Overview
7.9.3 RegenMedTX LLC Coronary Artery Bypass Graft Surgery Pipeline Major Product Offerings
7.9.4 RegenMedTX LLC Coronary Artery Bypass Graft Surgery Pipeline Sales and Revenue in Global (2018-2023)
7.9.5 RegenMedTX LLC Key News & Latest Developments
7.10 Elana bv
7.10.1 Elana bv Company Summary
7.10.2 Elana bv Business Overview
7.10.3 Elana bv Coronary Artery Bypass Graft Surgery Pipeline Major Product Offerings
7.10.4 Elana bv Coronary Artery Bypass Graft Surgery Pipeline Sales and Revenue in Global (2018-2023)
7.10.5 Elana bv Key News & Latest Developments
7.11 Rox Medical Inc
7.11.1 Rox Medical Inc Company Summary
7.11.2 Rox Medical Inc Coronary Artery Bypass Graft Surgery Pipeline Business Overview
7.11.3 Rox Medical Inc Coronary Artery Bypass Graft Surgery Pipeline Major Product Offerings
7.11.4 Rox Medical Inc Coronary Artery Bypass Graft Surgery Pipeline Sales and Revenue in Global (2018-2023)
7.11.5 Rox Medical Inc Key News & Latest Developments
7.12 Synovis Micro Companies Alliance Inc
7.12.1 Synovis Micro Companies Alliance Inc Company Summary
7.12.2 Synovis Micro Companies Alliance Inc Coronary Artery Bypass Graft Surgery Pipeline Business Overview
7.12.3 Synovis Micro Companies Alliance Inc Coronary Artery Bypass Graft Surgery Pipeline Major Product Offerings
7.12.4 Synovis Micro Companies Alliance Inc Coronary Artery Bypass Graft Surgery Pipeline Sales and Revenue in Global (2018-2023)
7.12.5 Synovis Micro Companies Alliance Inc Key News & Latest Developments
7.13 Thoratec LLC
7.13.1 Thoratec LLC Company Summary
7.13.2 Thoratec LLC Coronary Artery Bypass Graft Surgery Pipeline Business Overview
7.13.3 Thoratec LLC Coronary Artery Bypass Graft Surgery Pipeline Major Product Offerings
7.13.4 Thoratec LLC Coronary Artery Bypass Graft Surgery Pipeline Sales and Revenue in Global (2018-2023)
7.13.5 Thoratec LLC Key News & Latest Developments
7.14 SeamVad Ltd.
7.14.1 SeamVad Ltd. Company Summary
7.14.2 SeamVad Ltd. Business Overview
7.14.3 SeamVad Ltd. Coronary Artery Bypass Graft Surgery Pipeline Major Product Offerings
7.14.4 SeamVad Ltd. Coronary Artery Bypass Graft Surgery Pipeline Sales and Revenue in Global (2018-2023)
7.14.5 SeamVad Ltd. Key News & Latest Developments
7.15 Xeltis AG
7.15.1 Xeltis AG Company Summary
7.15.2 Xeltis AG Business Overview
7.15.3 Xeltis AG Coronary Artery Bypass Graft Surgery Pipeline Major Product Offerings
7.15.4 Xeltis AG Coronary Artery Bypass Graft Surgery Pipeline Sales and Revenue in Global (2018-2023)
7.15.5 Xeltis AG Key News & Latest Developments
8 Global Coronary Artery Bypass Graft Surgery Pipeline Production Capacity, Analysis
8.1 Global Coronary Artery Bypass Graft Surgery Pipeline Production Capacity, 2018-2029
8.2 Coronary Artery Bypass Graft Surgery Pipeline Production Capacity of Key Manufacturers in Global Market
8.3 Global Coronary Artery Bypass Graft Surgery Pipeline Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Coronary Artery Bypass Graft Surgery Pipeline Supply Chain Analysis
10.1 Coronary Artery Bypass Graft Surgery Pipeline Industry Value Chain
10.2 Coronary Artery Bypass Graft Surgery Pipeline Upstream Market
10.3 Coronary Artery Bypass Graft Surgery Pipeline Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Coronary Artery Bypass Graft Surgery Pipeline Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer



*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/
※関連調査資料
  • 世界の冠動脈バイパス術用パイプライン市場2022年：市場規模予測（～2028年）
  • 管腔内冠動脈ステントのグローバル市場展望 2023年-2029年：ベアメタルステント（BMS）、薬剤溶出ステント（DES）、生体吸収性スキャフォールド（BVS）
  • 腹腔鏡下胃バイパス手術装置のグローバル市場展望 2023年-2029年：スリーブ型胃切除術装置、調節可能型胃バンド、垂直帯胃形成術装置、その他
  • モスキート動脈鉗子のグローバル市場展望 2023年-2029年：ストレートティースモスキート動脈鉗子、カーブティースモスキート動脈鉗子
  • 心臓用薬剤コーティングバルーンのグローバル市場展望 2023年-2029年：パクリタキセルコーティング型、その他コーティング型
    • ※注目の調査資料
     ※当サイト上のレポートデータは弊社H&Iグローバルリサーチ運営のMarketReport.jpサイトと連動しています。
    ※当市場調査資料(MMG23LY7492 )"冠動脈バイパス移植手術用パイプラインのグローバル市場展望 2023年-2029年：内胸動脈手術用パイプライン、橈骨動脈手術用パイプライン、右胃大網動脈手術用パイプライン" (英文：Coronary Artery Bypass Graft Surgery Pipeline Market, Global Outlook and Forecast 2023-2029)はMarket Monitor Global社が調査・発行しており、H&Iグローバルリサーチが販売します。

    ◆H&Iグローバルリサーチのお客様（例）◆


    ※当サイトに掲載していない調査資料も弊社を通してご購入可能ですので、お気軽にご連絡ください。ウェブサイトでは紹介しきれない資料も数多くございます。
    ※無料翻訳ツールをご利用いただけます。翻訳可能なPDF納品ファイルが対象です。ご利用を希望されるお客様はご注文の時にその旨をお申し出ください。